Innosys Completes 8 Billion Won Capital Increase from J-Space... "Accelerating the Space Industry"

[Asia Economy Reporter Jang Hyowon] Innosis (CEO Choi Doyoung) announced on the 27th that the payment for the 8 billion KRW third-party allotment capital increase has been completed. As a result, J Space Holdings has become the second largest shareholder of Innosis.

The third-party allottee is J Space Holdings (CEO Min Bonggi), which has business purposes including satellite manufacturing, UAM, and school zone solutions.

Innosis has received domestic clinical trial approval for the bioabsorbable metal "Lysomet" in the medical device business sector. The market is expecting sales in the medical device field, including clinical trial prospects and license-out opportunities. Additionally, in the battery pack sector, Innosis achieved 6 billion KRW in supply volume in the first half of the year through collaboration with LG Energy Solution and expects to expand supply in the second half.

With J Space Holdings becoming the second largest shareholder through this capital increase, it is anticipated that the company will also make a full-scale start in the space development business.

A company official stated, "We believe that this capital increase will dispel market concerns about new businesses, and it is worth watching and expecting how J Space Holdings will fit the new business."

This content was produced with the assistance of AI translation services.